LECTURES

1988

12/07: Annual symposium of Medicinal Chemistry - University of Antwerp, Belgium
The kappa-opioid pharmacophore in 6,7-benzomorphans

1989

11/30: Biotechnology course - University of Nijmegen, The Netherlands (Host: Dr. Ruud Konings)
Molecular modeling: principles and applications

1990

01/12: BIOS Lecture - University of Groningen, The Netherlands
Towards new sleeping sickness drugs by structure-based drug design

07/13: Protein Structural Aspects of Biotechnology. COMETT Advanced Course - University of Nijmegen, The Netherlands (invited speaker)
Protein engineering and drug design

11/26: 2nd Symposium on Biochemical Biotechnology - Villa Olmo, Como, Italy (Invited speaker)
Ab initio design of selective inhibitors of trypanosomal triosephosphate isomerase: toward new drugs against sleeping sickness

1991

04/15: INTERNATIONAL ORGANIZATION FOR CHEMISTRY IN DEVELOPMENT Meeting - Institute for Cellular Pathology, Brussels, Belgium (Host: Dr. Fred Opperdoes)
Rational design of anti-trypanosomal agents

06/10: University Centre for Pharmacy RUG - Groningen, The Netherlands (Host: Dr. Alan Horn)
The linked-fragment approach as a tool for inhibitor design: towards new drugs against trypanosomiasis

1992

None: due to relocation

1993

03/25: Seattle Protozoology Conference - Seattle, WA
Successful rational selective inhibition of a trypanosomal enzyme

05/27: Annual meeting of the American Crystallographic Association - Albuquerque, NM
Successful rational selective inhibition of a trypanosomal enzyme

08/19: Department of Pharmaceutical Sciences UCSF (Host: Dr. Irwin Kuntz)
Protein structure-based design for selective inhibition of glyceraldehyde-3-phosphate dehydrogenase: towards new drugs for the treatment of sleeping sickness

09/12: Albany Conference: Molecular Mechanisms of Drug Resistance - Rensselaerville, NY (Invited speaker)
Drug design in protozoa

09/16: BIOSYM Scientific Seminar Series - Seattle, WA(Invited speaker)
Successful rational selective inhibition of a trypanosomal enzyme

11/22: BASF - Ludwigshafen, Germany (Host: Dr. Hans-Joachim Boehm)
Protein structure-based drug design: from an aspecific lead to a 500-fold gain in selectivity

1994

02/25: Department of Biological Structure Seminar - Seattle , WA
Protein structure-based inhibitor design for tropical diseases

04/11: The third Pacific Northwest Protein Crystallography Workshop - Seattle
Protein structure-based inhibitor design: expectations and facts

07/27: 3rd International satellite meeting: on the conformational analysis of carbohydrates & protein/carbohydrate interactions - Val Morin, Canada (Invited speaker)
Characterization of the carbohydrate receptor site in the cholera toxin family and its exploitation for drug design

09/02: 15th European Crystallographic Meeting - Dresden, Germany (Invited speaker)
Selective protein structure-based drug design:toward new drugs for the treatment of sleeping sickness

1995

01/20: Faculty Candidate Seminar - University of Washington, Seattle, WA
Protein structure-based drug design: fact or fiction?

02/09: Looking at protein structures and nucleic acids - University of Leuven, Belgium (Invited speaker)
Towards new drugs against trypanosomiasis and cholera: drug design on the basis of protein structures

05/24: 36th Annual Buffalo Medicinal Chemistry Symposium - Buffalo (Session organizer and speaker)
Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based drug design: toward new drugs for the treatment of sleeping sickness

07/28: Annual meeting of the American Crystallographic Association - Montreal (Session organizer and speaker)
Protein structure-based drug design: progress, results and challenges

1996

03/01/96: Medicinal Chemistry Seminar - University of Washington, Seattle (Host: Dr. Valerie Daggett)
Structure-based drug design: recipes for success

04/17/96: Biochemistry Dept., Wake Forest University, Winston-Salem, NC (Host: Dr. Al Claiborne)
Structure-based Drug Design for Tropical Diseases

04/19/96: 4th Bud Suddath Memorial Symposium - Georgia Institute of Technology, Atlanta (Host: Dr. Jim Powers)
Structure-based Drug Design for Tropical Diseases

04/26/96: UAB Structure-based drug design Conference - Panama City Beach (Invited speaker)
Structure-Based Optimization of Poor Leads: From high millimolar to low micromolar inhibitors

1997

01/28: UW Computer Science & Engineering (Host: Dr. Richard Karp; televised on UW TV channel)
Computational and algorithmic challenges in structure-based drug design

07/29: 662nd British Biochemical Society Meeting - Dundee, Schotland (Invited speaker)
Selective inhibition of glycolysis in tropical parasites by structure-based drug design

08/01: University of York, Department of Chemistry - York,UK (Host: Dr. Koen Verschueren)
Selective inhibition of glycolysis in tropical parasites by structure-based drug design

08/04: University of Leicester, Department of Biochemistry - Leicester, UK (Host: Dr. Tina Izard)
Selective inhibition of glycolysis in tropical parasites by structure-based drug design

09/11: American Chemical Society Meeting - Las Vegas (Invited speaker)
Anchor-based drug design

1998

12/07: INABIS (Internet Association for BIomedical Sciences) '98: 5th Internet World Congress on Biomedical Sciences (Invited speaker)
Five Orders of Magnitude Affinity Gain in Anti-trypanosomal Drug Development
available from URL: http://www.mcmaster.ca/inabis98/pharmtox/verlinde0900/index.html

1999

01/25: University of British Columbia, Department of Biochemistry and Molecular Biology - Vancouver, Canada (Host: Dr. Michael Murphy)
Five Orders of Magnitude Affinity Gain in Anti-trypanosomal Drug Development by Structure-based Design

03/23: DowAgrochemicals, Indianapolis, IN (Host: Dr. Terry Walsh)
Five Orders Affinity Gain by Selective Structure-based Design

05/25: Annual meeting of the American Crystallographic Association - Buffalo
Five Orders of Magnitude Affinity Gain in Anti-trypanosomal Drug Development by Structure-based Design

06/03: General Meeting of the American Society of Microbiology - Chicago (Invited speaker)
Structure-based Drug Design

10/21: Christan de Duve Institute of Cellular Pathology - Universite Catholique de Louvain - Belgium (Host: Dr. Paul Michels)
Structure-based strategies for disabling cholera toxin and heat-labile enterotoxin, masters of cellular trafficking

11/10: Eli-Lilly - Indianapolis (Host: Dr. Genshi Zhao)
Five Orders of Magnitude Affinity Gain in Anti-trypanosomal Drug Development by Structure-based Design

2000

04/19: UW Biophysics Seminar
A new and fast molecular docking approach: stochastic approximation with smoothing

2001

01/17: Nortwestern University - Chicago (Host: Dr. Brian Shoichet)
A new and fast molecular docking approach: stochastic approximation with smoothing

6/20: "Modeling of protein interactions in genomes", Charleston, SC (Invited speaker)
A new and fast molecular docking approach: stochastic approximation with smoothing

7/23: Structural GenomiX, San Diego, CA (Host: Dr. Mike Milburn)
Structure-based design: a case study and a new algorithm

8/26: ACS National Meeting Chicago (Invited speaker)
A new and fast molecular docking approach: stochastic approximation with smoothing

11/11: 1st Brazilian Symposium on Medicinal Chemistry "New apporaches in drug design" Caxambu, Minas Gerais, Brazil (Invited keynote speaker)
Protein structure-based design of antiprotozoal drugs

2002-2004

None, due to long term hospitalization and slow recovery. Healthy now!

2005

11/11-12: Amauta 3rd International Course on Biomedical and Health Informatics, Lima, Peru (Invited speaker)
Protein structure-based design: methods and practice
 

POSTERS

03/25/83: X-ray Crystallography and Drug Design - Erice, Sicily, Italy
Putative kappa-agonists: The crystal structure of ketazocine

08/11/83: 8th European Crystallography Meeting - Liege, Belgium
Putative kappa-agonists and the role of oxygen

01/11/83: SON Crystallography Meeting - Lunteren, The Netherlands
Structures of benzomorphan kappa-agonists

06/13/84: 25th Annual Medicinal Chemistry Symposium - Buffalo, NY
The opioid kappa-pharmacophore in benzomorphans: PCILO calculations of electronic properties and proton affinities, and molecular modeling

04/15/85: SON Crystallography Meeting - Lunteren, The Netherlands
Molecular mechanics: N-C-C-O torsional parameters in MM2. Crystal structures and CNDO/2 calculations

09/05/85: 9th European Crystallographic Meeting - Torino, Italy
The role of an extra oxygen atom in the opioid kappa pharmacophore of some benzomorphans

04/13/87: SON Crystallography Meeting - Lunteren, The Netherlands
Interpretation of static disorder: MM2 pucker analysis of a 2,2-disubstituted tetrahydrofuran ring

06/07/89: Three-dimensional Molecular Structure and Drug Design. A NATO Advanced Study Institute - Erice, Sicily, Italy
The sleeping sickness project

08/15/89: Prospects in Protein Engineering - Haren, The Netherlands
Protein structure-based design of new drugs against sleeping sickness

12/11/89: SON Protein Research Meeting - Lunteren, The Netherlands
Ab initio design of selectivity for gTIM inhibitors: potential drugs against sleeping sickness

12/10/90: SON Protein Research Meeting - Lunteren, The Netherlands
Progress in the design of inhibitors of the glycolytic enzymes of Trypanosoma brucei, the causative agent of sleeping sickness

09/11/91: 8th Camerino-Noordwijkerhout Symposium - Camerino, Italy
Pharmacological, structural and pharmacological analysis of 6,7-benzomorphans with kappa-agonistic activity. Modeling of the kappa-opioid pharmacophore

12/09/91: SON Protein Research Meeting - Lunteren, The Netherlands
Towards selective gGAPDH inhibitors: protein structure-based design

08/05/92: European Crystallographic Meeting, Enschede, The Netherlands
Protein structure-based inhibitor design: towards new drugs for trypanosomiasis

08/12/92: ACA Meeting, Pittsburgh, PA
Protein structure-based inhibitor design: towards new drugs for trypanosomiasis

03/14/95: 12th West Coast Protein Crystallography Workshop, Asilomar, CA
Structure-based drug design and tropical diseases

07/08/00: 6th NW Crystallography Workshop, Eugene, OR
A new and fast molecular docking approach: stochastic approximation with smoothing

10/13/00: UCSF Symposium "Drug design and discovery", San Fransisco, CA
A new and fast molecular docking approach: stochastic approximation with smoothing


contact: verlinde@u.washington.edu; tel: (206) 543 8865; fax: (206) 685 7002